GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Canntab Therapeutics Ltd (STU:TBF1) » Definitions » Receivables Turnover

Canntab Therapeutics (STU:TBF1) Receivables Turnover : 0.00 (As of Feb. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Canntab Therapeutics Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Canntab Therapeutics's Revenue for the three months ended in Feb. 2023 was €-0.02 Mil. Canntab Therapeutics's average Accounts Receivable for the three months ended in Feb. 2023 was €0.01 Mil.


Canntab Therapeutics Receivables Turnover Historical Data

The historical data trend for Canntab Therapeutics's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Canntab Therapeutics Receivables Turnover Chart

Canntab Therapeutics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 May17 May18 May19 May20 May21 May22
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.67 - - - 5.84

Canntab Therapeutics Quarterly Data
Mar18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.83 0.84 0.92 0.70 -

Competitive Comparison of Canntab Therapeutics's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Canntab Therapeutics's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Canntab Therapeutics's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Canntab Therapeutics's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Canntab Therapeutics's Receivables Turnover falls into.



Canntab Therapeutics Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Canntab Therapeutics's Receivables Turnover for the fiscal year that ended in May. 2022 is calculated as

Receivables Turnover (A: May. 2022 )
=Revenue / Average Total Inventories
=Revenue (A: May. 2022 ) / ((Accounts Receivable (A: May. 2021 ) + Accounts Receivable (A: May. 2022 )) / count )
=0.216 / ((0 + 0.037) / 1 )
=0.216 / 0.037
=5.84

Canntab Therapeutics's Receivables Turnover for the quarter that ended in Feb. 2023 is calculated as

Receivables Turnover (Q: Feb. 2023 )
=Revenue / Average Total Inventories
=Revenue (Q: Feb. 2023 ) / ((Accounts Receivable (Q: Nov. 2022 ) + Accounts Receivable (Q: Feb. 2023 )) / count )
=-0.015 / ((0.009 + 0.002) / 2 )
=-0.015 / 0.0055
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Canntab Therapeutics  (STU:TBF1) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Canntab Therapeutics Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Canntab Therapeutics's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Canntab Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
1 Adelaide Street East, Suite 801, Toronto, ON, CAN, M5C 2V9
Canntab Therapeutics Ltd is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. It has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use.

Canntab Therapeutics Headlines

No Headlines